Dana-Farber Cancer Institute Merrimack Valley

Methuen, Massachusetts 01844

3 studies enrolling now · 6 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Breast Cancer, Breast Neoplasms, High-risk Smoldering Multiple Myeloma, Metastatic Breast Cancer, Metastatic Non-Small Cell Lung Cancer, Multiple Myeloma, Survivorship, Treatment Adherence, Treatment Compliance, Treatment Refusal

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• DARA RVD For High Risk SMM — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• Culturally Aware AET Non-Initiation Intervention — Completed